Updated Jul 16, 2026
Galitzer Hillel has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Hillel Galitzer is the Chief Operating Officer at Entera Bio Ltd., a biopharmaceutical company focused on developing oral drug delivery systems. His role involves overseeing the company's operations and strategic initiatives.
| Role | Chief Operating Officer |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-08 | ENTX | Entera Bio Ltd. | A — Grant or award | 73.0K | $0.00 |
Hillel Galitzer is the Chief Operating Officer at Entera Bio Ltd., a biopharmaceutical company focused on developing oral drug delivery systems. His role involves overseeing the company's operations and strategic initiatives.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Galitzer Hillel profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.